Clevenbergh P - Search Results

1

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.

Sow PS, Otieno LF, Bissagnene E, Kityo C, Bennink R, Clevenbergh P, Wit FW, Waalberg E, Rinke de Wit TF, Lange JM; Cohort Program to Evaluate Access to Antiretroviral Therapy and Education Project Team. Sow PS, et al. Among authors: clevenbergh p. J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):262-7. doi: 10.1097/QAI.0b013e31802bf109. J Acquir Immune Defic Syndr. 2007. PMID: 17146376 Clinical Trial.

2

Economic evaluation of drug resistance genotyping for the adaptation of treatment in HIV-infected patients in the VIRADAPT study.

Chaix C, Grenier-Sennelier C, Clevenbergh P, Durant J, Schapiro JM, Dellamonica P, Durand-Zaleski I. Chaix C, et al. Among authors: clevenbergh p. J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):227-31. doi: 10.1097/00126334-200007010-00005. J Acquir Immune Defic Syndr. 2000. PMID: 10969346 Clinical Trial.

3

Variable virological outcomes according to the center providing antiretroviral therapy within the PharmAdapt clinical trial.

Clevenbergh P, Bozonnat MC, Kirstetter M, Durant J, Cua E, del Giudice P, Montagne N, Simonet P; Group InfectioSud. Clevenbergh P, et al. HIV Clin Trials. 2003 Mar-Apr;4(2):84-91. doi: 10.1310/788w-paub-8e8q-y7l5. HIV Clin Trials. 2003. PMID: 12671775 Clinical Trial.

4

Efficacy, safety and predictive factors of virological success of a boosted amprenavir-based salvage regimen in heavily antiretroviral-experienced HIV-1-infected patients.

Clevenbergh P, Boulmé R, Kirstetter M, Dellamonica P. Clevenbergh P, et al. HIV Med. 2004 Jul;5(4):284-8. doi: 10.1111/j.1468-1293.2004.00222.x. HIV Med. 2004. PMID: 15236618 Free article. Clinical Trial.

5

Database-supported teleconferencing: an additional clinical mentoring tool to assist a multinational company HIV/AIDS treatment program in Africa.

Clevenbergh P, Van der Borght SF, van Cranenburgh K, Janssens V, Kitenge Lubangi C, Gahimbaza L, Lange JM, Rinke de Wit TF, Rijckborst H. Clevenbergh P, et al. HIV Clin Trials. 2006 Sep-Oct;7(5):255-62. doi: 10.1310/hct0705-255. HIV Clin Trials. 2006. PMID: 17162320

6

Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.

Van der Borght SF, Clevenbergh P, Rijckborst H, Nsalou P, Onyia N, Lange JM, de Wit TF, Van der Loeff MF. Van der Borght SF, et al. Among authors: clevenbergh p. Antivir Ther. 2009;14(1):63-74. Antivir Ther. 2009. PMID: 19320238

7

Long-term voluntary counseling and testing (VCT) uptake dynamics in a multicountry HIV workplace program in sub-Saharan Africa.

Van der Borght SF, Schim van der Loeff MF, Clevenbergh P, Kabarega JP, Kamo E, van Cranenburgh K, Rijckborst H, Lange JM, Rinke de Wit TF. Van der Borght SF, et al. Among authors: clevenbergh p. AIDS Care. 2010 Feb;22(2):195-205. doi: 10.1080/09540120903111486. AIDS Care. 2010. PMID: 20390498

8

Early CD4(+) T cell recovery in human immunodeficiency virus-infected patients receiving effective therapy is related to a down-regulation of apoptosis and not to proliferation.

Roger PM, Breittmayer JP, Durant J, Sanderson F, Ceppi C, Brignone C, Cua E, Clevenbergh P, Fuzibet JG, Pesce A, Bernard A, Dellamonica P; Groupe d'Etudes Niçois Polyvalent en Infectiologie. Roger PM, et al. Among authors: clevenbergh p. J Infect Dis. 2002 Feb 15;185(4):463-70. doi: 10.1086/338573. Epub 2002 Jan 31. J Infect Dis. 2002. PMID: 11865398

9

Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.

Okome-Nkoumou M, Guiyedi V, Ondounda M, Efire N, Clevenbergh P, Dibo M, Dzeing-Ella A. Okome-Nkoumou M, et al. Among authors: clevenbergh p. Am J Trop Med Hyg. 2014 Feb;90(2):211-5. doi: 10.4269/ajtmh.12-0780. Epub 2013 Dec 9. Am J Trop Med Hyg. 2014. PMID: 24323514 Free PMC article.

10

Is There a Need for Viral Load Testing to Assess Treatment Failure in HIV-Infected Patients Who Are about to Change to Tenofovir-Based First-Line Antiretroviral Therapy? Programmatic Findings from Myanmar.

Thiha N, Chinnakali P, Harries AD, Shwe M, Balathandan TP, Thein Than Tun S, Das M, Tin HH, Yi Y, Babin FX, Lwin TT, Clevenbergh PA. Thiha N, et al. Among authors: clevenbergh pa. PLoS One. 2016 Aug 9;11(8):e0160616. doi: 10.1371/journal.pone.0160616. eCollection 2016. PLoS One. 2016. PMID: 27505228 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters